Literature DB >> 8489858

Impaired coronary flow reserve immediately after coronary angioplasty in patients with acute myocardial infarction.

M Ishihara1, H Sato, H Tateishi, T Kawagoe, M Yoshimura, Y Muraoka.   

Abstract

OBJECTIVE: To examine coronary flow reserve immediately after emergency coronary angioplasty in patients with acute myocardial infarction.
DESIGN: A 3 F coronary Doppler catheter was used to measure coronary blood flow velocity in the infarct artery and in the non-infarct artery. Maximal hyperaemia was produced by 10 mg of intracoronary papaverine and coronary flow reserve was calculated. PATIENTS: 11 patients with acute myocardial infarction undergoing both emergency coronary angioplasty (4.7 (3.6) h after the onset of chest pain (mean (SD))) and at follow up catheterisation 16 (4) days after angioplasty.
SETTING: Hiroshima City Hospital.
RESULTS: There was no stenosis of > or = 50% in the coronary artery of interest. Immediately after coronary angioplasty the mean (1 SD) coronary flow reserve of the infarct artery was significantly less than that of the non-infarct artery (1.4 (0.4) v 2.8 (0.8), p < 0.001). At follow up catheterisation the coronary flow reserve of the infarct artery increased almost to the value of the non-infarct artery (2.8 (1.2) v 3.1 (0.8) p = NS).
CONCLUSION: The coronary flow reserve in the infarct region was severely impaired immediately after reperfusion, even with a widely patent infarct artery. This could restrict the beneficial effects of reperfusion therapy, especially when there is a severe residual stenosis.

Entities:  

Mesh:

Year:  1993        PMID: 8489858      PMCID: PMC1025038          DOI: 10.1136/hrt.69.4.288

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  21 in total

1.  Changes in the microvasculature of ischemic and infarcted myocardium.

Authors:  L C Armiger; J B Gavin
Journal:  Lab Invest       Date:  1975-07       Impact factor: 5.662

2.  Intraaortic balloon pumping as the postangioplasty strategy in acute myocardial infarction.

Authors:  M Ishihara; H Sato; H Tateishi; T Uchida; K Dote
Journal:  Am Heart J       Date:  1991-08       Impact factor: 4.749

3.  Platelet aggregation in partially obstructed vessels and its elimination with aspirin.

Authors:  J D Folts; E B Crowell; G G Rowe
Journal:  Circulation       Date:  1976-09       Impact factor: 29.690

4.  Coronary reperfusion: effects of vasodilators (papaverine and adenosine).

Authors:  P E Parker; F A Bashour; H F Downey; I S Boutros
Journal:  Am Heart J       Date:  1977-01       Impact factor: 4.749

5.  Pressure-flow characteristics of coronary stenoses in unsedated dogs at rest and during coronary vasodilation.

Authors:  K L Gould
Journal:  Circ Res       Date:  1978-08       Impact factor: 17.367

6.  Coronary hemodynamics during reperfusion following acute coronary ligation in dogs.

Authors:  P E Parker; F A Bashour; H F Downey; S J Kechejian; A G Williams
Journal:  Am Heart J       Date:  1975-11       Impact factor: 4.749

7.  The injury-spasm (ischemia-induced hemostatic vasoconstrictive) and vascular autoregulatory hypothesis of ischemic disease. Resistance vessel-spasm hypothesis of ischemic disease.

Authors:  H R Hellstrom
Journal:  Am J Cardiol       Date:  1982-03       Impact factor: 2.778

8.  The effect of an isovolumic left ventricle on the coronary vascular competence during reflow after global ischemia in the rat heart.

Authors:  S M Humphrey; R W Thomson; J B Gavin
Journal:  Circ Res       Date:  1981-09       Impact factor: 17.367

9.  Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog.

Authors:  R L Engler; G W Schmid-Schönbein; R S Pavelec
Journal:  Am J Pathol       Date:  1983-04       Impact factor: 4.307

10.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

Authors:  R A Kloner; C E Ganote; R B Jennings
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

View more
  10 in total

1.  Reperfusion Injury: Does It Exist and Does It Have Clinical Relevance?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

2.  Can coronary flow velocity reserve determined by transthoracic Doppler echocardiography predict the recovery of regional left ventricular function in patients with acute myocardial infarction?

Authors:  Y Ueno; Y Nakamura; M Kinoshita; T Fujita; T Sakamoto; H Okamura
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

3.  Time-course of dobutamine-induced wall motion abnormalities in the infarct area following thrombolytic therapy.

Authors:  R Bigi; G Curti; C Sponzilli; D Castini; G Occhi; C Fiorentini
Journal:  Int J Card Imaging       Date:  1998-12

Review 4.  Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests.

Authors:  Hernán Mejía-Rentería; Nina van der Hoeven; Tim P van de Hoef; Julius Heemelaar; Nicola Ryan; Amir Lerman; Niels van Royen; Javier Escaned
Journal:  Int J Cardiovasc Imaging       Date:  2017-05-13       Impact factor: 2.357

5.  Coronary flow reserve.

Authors:  P Collins
Journal:  Br Heart J       Date:  1993-04

6.  Does primary stenting preserve cardiac function in myocardial infarction? A case-control study. NORTH-981 investigators. Network of revascularisation therapy in Hokkaido.

Authors:  H Sasao; K Tsuchihashi; M Hase; T Nakata; K Shimamoto
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

7.  Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats.

Authors:  Natia Q Kelm; Jason E Beare; Amanda J LeBlanc
Journal:  J Vis Exp       Date:  2019-06-28       Impact factor: 1.355

8.  Estimation of coronary flow reserve by intracoronary administration of nicorandil: comparison with intracoronary administration of papaverine.

Authors:  F Inoue; T Hashimoto; S Fujimoto; S Uemura; A Kawamoto; K Dohi
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

9.  Prevalence of microvascular disease in patients with significant coronary artery disease.

Authors:  J Qian; J Ge; D Baumgart; S Sack; M Haude; R Erbel
Journal:  Herz       Date:  1999-11       Impact factor: 1.443

10.  Arginase inhibition improves coronary microvascular function and reduces infarct size following ischaemia-reperfusion in a rat model.

Authors:  J Grönros; A Kiss; M Palmér; C Jung; D Berkowitz; J Pernow
Journal:  Acta Physiol (Oxf)       Date:  2013-04-15       Impact factor: 6.311

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.